Mealey's (July 24, 2020, 5:42 PM EDT) -- BOISE, Idaho — An Idaho state court judge on July 13 dismissed a fraud claim against Novartis Pharmaceuticals Corp. in a Brethine birth defect case, finding that the time between when Novartis marketed the drug to Idaho doctors and the alleged injury is insufficient to establish minimum contacts and confer personal jurisdiction over the defendant (Michelle Stirling, et al. v. Novartis Pharmaceuticals Corporation, et al., No. CV01-18-04880, Idaho Dist., Ada Co.)....